These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11346192)

  • 1. Antipsychotic-induced weight gain: a review of the literature.
    Allison DB; Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 7():22-31. PubMed ID: 11346192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive behavior therapy for weight gain.
    Umbricht D; Flury H; Bridler R
    Am J Psychiatry; 2001 Jun; 158(6):971. PubMed ID: 11384925
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain and antipsychotic medications.
    Aquila R; Emanuel M
    J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
    [No Abstract]   [Full Text] [Related]  

  • 6. Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
    Webster D; Devarajan S; Gallant J; Harris A; Kopala LC
    Schizophr Res; 2002 Jul; 56(1-2):187-9. PubMed ID: 12084432
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of weight gain with antipsychotics.
    Casey DE; Zorn SH
    J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
    Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
    Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of atypical antipsychotics and weight gain.
    Sussman N
    J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.
    Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
    Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
    Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of olanzapine-induced weight gain with an increase in body fat.
    Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW
    Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index increase of 58% associated with olanzapine.
    Bryden KE; Kopala LC
    Am J Psychiatry; 1999 Nov; 156(11):1835-6. PubMed ID: 10553757
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.